Approvals/CIMA-AEMPS/AMBRISENTAN SALA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

AMBRISENTAN SALA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Laboratorio Reig Jofre, S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 3076a9bcc2979760
Drug Cima Aemps Name: AMBRISENTAN SALA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86090
Holder Company Name: Laboratorio Reig Jofre, S.A.
Marketing Company Name: Laboratorio Reig Jofre, S.A.
Authorization Date: 2021-07-14
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 10 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Laboratorio Reig Jofre, S.A.

AMBRISENTAN

10 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 14, 2021

Approval ID

3076a9bcc2979760

Type

Standard